Labetuzumab: differenze tra le versioni

Da Wikipedia, l'enciclopedia libera.
Vai alla navigazione Vai alla ricerca
Contenuto cancellato Contenuto aggiunto
ins. testo tradotto da en.wiki
 
→‎Note: ins. bibl.
Riga 39: Riga 39:
== Note ==
== Note ==
<references/>
<references/>

== Bibliografia ==
* {{cite book|author=Frank Ashall|title=Le grandi scoperte scientifiche|url=http://books.google.com/books?id=GXsecqAh6MEC&pg=PA245|accessdate=|year=1999|publisher=Armando Editore|isbn=9788871449494|pages=245–}}
* {{cite book|author1=Abul K. Abbas|author2=Andrew H. Lichtman|author3=Shiv Pillai|title=Immunologia cellulare e molecolare|url=http://books.google.com/books?id=9SFm3nMO_gUC&pg=PA79|accessdate= |year=2010|publisher=Elsevier srl|isbn=9788821431760|pages=79–}}
* {{cite book|author1=Abul K. Abbas|author2=Andrew H. Lichtman|title=Le basi dell'immunologia|url=http://books.google.com/books?id=szHkdI9buskC&pg=PA70|accessdate|year=2006|publisher=Elsevier srl|isbn=9788885675858|pages=70–}}
* {{cite book|author1=Humphrey P. Rang|author2=M. Maureen Dale|author3=James M. Ritter|title=Farmacologia|url=http://books.google.com/books?id=HGcP_ip4SmgC&pg=PA778|accessdate|year=2008|publisher=Elsevier srl|isbn=9788821430237|pages=778–}}
* {{cite book|author=Enzo Fagiolo|title=Immunoematologia|url=http://books.google.com/books?id=ErRtMU7SKhkC&pg=PA16|accessdate=|year=2007|publisher=Mediserve s.r.l.|isbn=9788882041359|pages=16–}}
* {{cite book|author=Paolo Larizza|title=Trattato di medicina interna|url=http://books.google.com/books?id=Rt4_C55_Ls4C&pg=PA909|accessdate=|year=2005|publisher=PICCIN|isbn=9788829917211|pages=909–}}
* {{cite book|author=Angelo Sghirlanzoni|title=Terapia Delle Malattie Neurologiche|url=http://books.google.com/books?id=LCNUGXlL4FQC&pg=PA113|accessdate= |date=3 April 2010|publisher=Springer|isbn=9788847011199|pages=113–}}
* {{cite book|author=Thomas C. King|title=Patologia|url=http://books.google.com/books?id=1CgV-Td_I3oC&pg=PA156|accessdate= |year=2008|publisher=Elsevier srl|isbn=9788821430190|pages=156–}}
* {{cite web | url = http://whqlibdoc.who.int/druginfo/INN_2000_list43.pdf WHO-Lista INN degli Anticorpi monoclonali| title = whqlibdoc.who.int | author = | authorlink = | coauthors = | date =|format = | work = | publisher = | pages = | language = en | archiveurl = | archivedate = | quote =| accessdate = }}
* {{en}}{{cite book|author=Marie A. Simmons|title=Monoclonal antibodies: new research|url=http://books.google.com/books?id=jxhKskARw6IC|accessdate=|year=2005|publisher=Nova Publishers|isbn=9781594542473}}
* {{en}}{{cite book|author=Zhiqiang An|title=Therapeutic Monoclonal Antibodies: From Bench to Clinic|url=http://books.google.com/books?id=agdx2rtK7E0C|accessdate= |date=8 September 2009|publisher=John Wiley and Sons|isbn=9780470117910}}
* {{en}}{{cite book|author=James W. Goding|title=Monoclonal antibodies: principles and practice : production and application of monoclonal antibodies in cell biology, biochemistry and immunology|url=http://books.google.com/books?id=jPk4ZY4CnQQC|accessdate=|year=1996|publisher=Academic Press|isbn=9780122870231}}
* {{en}}{{cite book|author=Steve Shire|title=Current Trends in Monoclonal Antibody Development and Manufacturing|url=http://books.google.com/books?id=YTbJpdPhgT4C|accessdate= |date=April 2009|publisher=Springer|isbn=9780387766423}}

=== Labetuzumab ===
* {{en}}{{cite book|author1=Edward C. Halperin|author2=Carlos A. Perez|author3=Luther W. Brady|title=Perez and Brady's principles and practice of radiation oncology|url=http://books.google.com/books?id=NyeE6-aKnSYC&pg=PA590|accessdate=27 March 2011|year=2008|publisher=Lippincott Williams & Wilkins|isbn=9780781763691|pages=590–}}
* {{en}}{{cite book|author=Felix Bronner|title=Bone and Cancer|url=http://books.google.com/books?id=NW05ElZsGBUC&pg=PA222|accessdate= |date=21 May 2009|publisher=Springer|isbn=9781848820180|pages=222–}}
* {{en}}{{cite book|author1=Waun Ki Hong|author2=Robert C. Bast|author3=William Hait|coauthors=Donald W. Kufe, James F. Holland, Raphael E. Pollock, Ralph R. Weichselbaum|title=Holland Frei cancer medicine eight|url=http://books.google.com/books?id=R0FbhLsWHBEC&pg=PA719|accessdate= |year=2010|publisher=PMPH-USA|isbn=9781607950141|pages=719–}}
* {{en}}{{cite book|author=William Small|title=Combining targeted biological agents with radiotherapy: current status and future directions|url=http://books.google.com/books?id=SFUF4c9k3LUC&pg=PA99|accessdate= |year=2008|publisher=Demos Medical Publishing|isbn=9781933864341|pages=99–}}


{{Portale|medicina}}
{{Portale|medicina}}

Versione delle 13:20, 27 mar 2011

Template:Disclaimer medico Template:Farmaco

Il labetuzumab, commercializzato con il nome commerciale CEA-CIDE è un anticorpo monoclonale umanizzato (IgG1) studiato per il trattamento del cancro colon-rettale.

Questo farmaco è stato sviluppato da Immunomedics, Inc.[1]

Il target molecolare del farmaco è l'antigene carcino-embrionico (carcinoembryonic antigen).

Note

Bibliografia

Labetuzumab

  Portale Medicina: accedi alle voci di Wikipedia che trattano di medicina